Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

  • [1]Ellis TL, Neal MT, Chan MD: The role of surgery, radiosurgery and whole brain radiation therapy in the management of patients with metastatic brain tumors. Int J Surg Oncol 2012, 952345 (2011)

  • [2]Truman JP, Garcia-Barros M, Kaag M, Hambardzumyan D, Stancevic B, Chan M, Fuks Z, Kolesnick R, Haimovitz-Friedman A: Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery. PLoS One 5, e12310 (2010)

  • [3]Lester SC, Taksler GB, Kuremsky JG, Lucas JT, Jr., Ayala-Peacock DN, Randolph DM, 2nd, Bourland JD, Laxton AW, Tatter SB, Chan MD: Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Cancer 120, 433-41 (2014)

  • [4]Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Hayakawa K, Katoh N, Kobashi G: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295, 2483-91 (2006)

  • [5]Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shui AS, Maor MH, Meyers CA: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10, 1037-44 (2009)

  • [6]Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A: A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31, 65-72 (2013)

  • [7]Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, Yamanaka K, Sato Y, Jokura H, Yomo S, Nagano O, Kenal H, Moriki A, Suzuki S, Kida Y, Iwai Y, Hayashi M, Onishi H, Gondo M, Sato M, Akimitsu T, Kubo K, Kikuchi Y, Shibasaki T, Goto T, Takanashi M, Mori Y, Takakura K, Saeki N, Kunieda E, Aoyama H, Momoshima S, Tsuchiya K: Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15, 387-95 (2014)

  • [8]Halasz LM, Weeks JC, Neville BA, Taback N, Punglia RS: Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States. Int J Radiat Oncol Biol Phys 85, e109-16 (2013)

  • [9]Thomas EM, Popple RA, Wu X, Clark GM, Markert JM, Guthrie BL, Yuan Y, Dobelbower MC, Spencer SA, Fiveash JB: Comparison of plan quality and delivery time between volumetric arc therapy (RapidArc) and Gamma Knife radiosurgery for multiple cranial metastases. Neurosurgery 75, 409-17 (2014)

  • [10]Greene-Schloesser D, Robbins ME, Peiffer AM, Shaw EG, Wheeler KT, Chan MD: Radiation-induced brain injury: A review. Front Oncol 2, 73 (2012)

  • [11]Attia A, Page BR, Lesser GJ, Chan M: Treatment of radiation-induced cognitive decline. Curr Treat Options Oncol 15, 539-50 (2014)

  • [12]Sahgal A, Larson D, Knisely J: Stereotactic radiosurgery alone for brain metastases. Lancet Oncol 16, 249-50 (2015)

  • [13]Engh JA, Flickinger JC, Niranjan A, Amin DV, Kondziolka DS, Lunsford LD: Optimizing intracranial metastasis detection for stereotactic radiosurgery. Stereotact Funct Neurosurg 85, 162-8 (2007)

  • [14]Subedi KS, Takahashi T, Yamano T, Saitoh J, Nishimura K, Suzuki Y, Ohno T, Nakano T: Usefulness of double dose contrast-enhanced magnetic resonance imaging for clear delineation of gross tumor volume in stereotactic radiotherapy treatment planning of metastatic brain tumors: a dose comparison study: J Radiat Res 54, 135-9 (2013)

  • [15]Yuh WT, Tali ET, Nguyen HD, Simonson TM, Mayr NA, Fisher DJ: The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 16, 373-80 (1995)

  • [16]Sze G, Johnson C, Kawamura Y, Goldberg SN, Lange R, Friedland RJ, Wolf RJ: Comparison of single-and triple-dose contrast material in the MR screening of brain metastases. AJNR Am J Neuroradiol 19, 821-8 (1998)

  • [17]Anzalone N, Gerevini S, Scotti R, Vezzulli P, Picozzi P: Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine. Acta Radiol 50, 933-40 (2009)

  • [18]Saconn PA, Shaw EG, Chan MD, Squire SE, Johnson AJ, McMullen KP, Tatter SB, Ellis TL, Lovato J, Bourland JD, Ekstrand KE, DeGuzman AF, Munley MT: Use of 3.0.-T MRI for stereotactic radiosurgery planning for treatment of brain metastases: a single-institution retrospective review. Int J Radiat Oncol Biol Phys 78, 1142-6 (2009)

  • [19]Loganathan AG, Chan MD, Alphonse N, Peiffer AM, Johnson AJ, McMullen KP, Urbanic JJ, Saconn PA, Bourland JD, Munley MT, Shaw EG, Tatter SB, Ellis TL: Clinical outcomes of brain metastases treated with Gamma Knife radiosurgery with 3.0. T versus 1.5. T MRI-based treatment planning: have we finally optimised detection of occult brain metastases? J Med Imaging Radiat Oncol 56, 554-60 (2012)

  • [20]Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47, 291-8 (2000)

  • [21]Shiau CY, Sneed PK, Shu HK, Lamborn KR, McDermott MW, Chang S, Nowak P, Petti PL, Smith V, Verhey LJ, Ho M, Park E, Wara WM, Gutin PH, Larson DA: Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 37, 375-83 (1997)

  • [22]Lucas J, Colmer H, White L, Fitzgerald N, Isom S, Bourland JD, Laxton AW, Tatter SB, Chan MD: Competing Risk Analysis of Neurologic vs. Non-Neurologic Death in Patients Undergoing Radiosurgical Salvage Following Whole Brain Radiotherapy Failure (WBRT): Who Actually Dies of Their Brain Metastases? Int J Radiat Oncol Biol Phys 92, 1008-15 (2015)

  • [23]Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363, 1665-72 (2004)

  • [24]Jensen CA, Chan MD, McCoy TP, Bourland JD, deGuzman AF, Ellis TL, Ekstrand KE, McMullen KP, Munley MT, Shaw EG, Urbanic JJ, Tatter SB: Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg 114, 1585-91 (2011)

  • [25]Eaton BR, Gebhardt B, Prabhu R, Shu HK, Curran WJ, Jr., Crocker I: Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation. Radiat Oncol 8, 135 (2013)

  • [26]Feuvret L, Vinchon S, Martin V, Lamproglou I, Halley A, Calugaru V, Chea M, Valery CA, Simon JM, Mazeron JJ: Stereotactic radiotherapy for large solitary brain metastases. Cancer Radiother 18, 97-106 (2014)

  • [27]Yomo S, Hayashi M, Nicholson C: A prospective pilot study of two-session Gamma Knife surgery for large metastatic brain tumors. J Neurooncol 109, 159-65 (2012)

  • [28]Yomo S, Hayashi M: A minimally invasive treatment option for large metastatic brain tumors: long-term results of two-session Gamma Knife stereotactic radiosurgery. Radiat Oncol 9, 132 (2014)

  • [29]Cochran DC, Chan MD, Aklilu M, Lovato JF, Alphonse NK, Bourland JD, Urbanic JJ, McMullen KP, Shaw EG, Tatter SB, Ellis TL: The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. J Neurosurg 116, 978-83 (2012)

  • [30]Harris S, Chan MD, Lovato JF, Ellis TL, Tatter SB, Bourland JD, Munley MT, deGuzman AF, Shaw EG, Urbanic JJ, McMullen KP: Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer. Int J Radiat Oncol Biol Phys 83, e53-9 (2012)

  • [31]Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland JD, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD: Impact of Systemic Targeted Agents on the Clinical Outcomes of Patients with Brain Metastases. Oncotarget (2015)

  • [32]MedSolutions I: MedSolutions Radiation Oncology Guidelines Version 3.0. 2015 (cited 2015 May 19, 2015)

  • [33]Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37, 745-51 (1997)

  • [34]Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M: Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30, 419-25 (2012)

  • [35]Ayala-Peacock DN, Peiffer AM, Lucas JT, Isom S, Kuremsky JG, Urbanic JJ, Bourland JD, Laxton AW, Tatter SB, Shaw EG, Chan MD: A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol 16, 1283-8 (2014)

  • [36]Sawrie SM, Guthrie BL, Spencer SA, Nordal RA, Meredith RF, Markert JM, Cloud GA, Fiveash JB: Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys 70, 181-6 (2008)

  • [37]Neal MT, Chan MD, Lucas JT, Jr., Loganathan A, Dillingham C, Pan E, Stewart JH 2nd, Bourland JD, Shaw EG, Tatter SB, Ellis TL: Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases. World Neurosurg 82, 1250-5 (2014)

  • [38]Ayala-Peacock D, Attia A, Hepel J, Lucas J, Onyeuku N, Stavas M, Taylor RB, Chung C, Fiveash J, Chan MD: A Multi-institutional Predictive Nomogram for Distant Brain Failure in Patients Treated with Upfront Stereotactic Radiosurgery Without Whole Brain Radiation Therapy. Int J Radiat Oncol‚ Biol‚ Phys 90, S126 (2014)

  • [39]Kuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL, McMullen KP, Shaw EG, Chan MD: Tumor Histology Predicts Patterns of Failure and Survival in Patients with Brain Metastases from Lung Cancer Treated with Gamma Knife Radiosurgery. Neurosurgery 73, 641-7 (2013)

  • [40]Vern-Gross TZ, Lawrence JA, Case LD, McMullen KP, Bourland JD, Metheny-Barlow LJ, Ellis TL, Tatter SB, Urbanic JJ, Chan MD: Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. J Neurooncol 110, 381-8 (2012)

  • [41]Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP: Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29, 134-41 (2011)

  • [42]Kilburn JM, Ellis TL, Lovato JF, Urbanic JJ, Daniel Bourland J, Munley MT, DeGuzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD: Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity? J Neurooncol 117, 167-74 (2014)

  • [43]Lucas J, Ayala-Peacock D, Piazza M, Kuremsky J, Page B, Randolph D, Fitzgerald N, Holmes JA, Soike M, Tatter SB, Chan MD: A Propensity Score Adjusted Analysis of Patients Receiving Up-Front SRS Versus WBRT: Does the Use of Upfront WBRT Really Affect Neurologic Death? Int J Radiat Oncol‚ Biol‚ Phys 90, S315-6 (2014)

  • [44]Stockham AL, Tievsky AL, Koyfman SA, Reddy CA, Suh JH, Vogelbaum MA, Barnett GH, Chao ST: Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery. J Neurooncol 109, 149-58 (2012)

  • [45]Ruzevick J, Kleinberg L, Rigamonti D: Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice. Neurosurg Rev 37, 193-201 (2014)

  • [46]Kim YZ, Kim DY, Yoo H, Yang HS, Shin SH, Hong EK, Cho KH, Lee SH: Radiation-induced necrosis deteriorating neurological symptoms and mimicking progression of brain metastasis after stereotactic-guided radiotherapy. Cancer Res Treat 39, 16-21 (2007)

  • [47]Chung JK, Kim YK, Kim SK, Lee YJ, Paek S, Yeo JS, Jeong JM, Lee DS, Jung HW, Lee MC: Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo-or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging 29, 176-82 (2002)

  • [48]Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schlepers C, Cloughesy T: 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 47, 904-11 (2006)

  • [49]Li DL, Xu YK, Wang QS, Wu HB, Li HS: (1)(1)C-methionine and (1)(8)F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas. Chin Med J (Engl) 125, 91-6 (2012)

  • [50]Boothe D, Young R, Yamada Y, Prager A, Chan T, Beal K: Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery. Neuro Oncol 15, 1257-63 (2013)

  • [51]Kohshi K, Imada H, Nomoto S, Yamaguchi R, Abe H, Yamamoto H: Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy. J Neurol Sci 209, 115-7 (2003)

  • [52]Parvez K, Parvez A, Zadeh G: The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence. Int J Mol Sci 15, 11832-46 (2014)

  • [53]Williamson R, Kondziolka D, Kanaan H, Lunsford LD, Flickinger JC: Adverse radiation effects after radiosurgery may benefit from oral vitamin E and pentoxifylline therapy: a pilot study. Stereotact Funct Neurosurg 86, 359-66 (2008)

  • [54]Rahmathulla G, Recinos PF, Valerio JE, Chao S, Barnett GH: Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review. Stereotact Funct Neurosurg 90, 192-200 (2012)

  • [55]Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B: Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280, 1485-9 (1998)

  • [56]Mu F, Lucas JT, Jr., Watts JM, Johnson AJ, Daniel Bourland J, Laxton AW, Chan MD, Tatter SB: Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis. J Clin Neurosci 22, 561-5 (2015)

  • [57]Rao MS, Hargreaves EL, Khan AJ, Haffty BG, Danish SF: Magnetic resonance-guided laser ablation improves local control for postradiosurgery recurrence and/or radiation necrosis. Neurosurgery 74, 658-67 (2014)

  • [58]Torres-Reveron J, Tomasiewicz HC, Shetty A, Amankulor NM, Chiang VL: Stereotactic laser induced thermotherapy (LITT): a novel treatment for brain lesions regrowing after radiosurgery. J Neurooncol 113, 495-503 (2013)

  • [59]Jayachandran P, Shultz D, Modlin L, Von Eyben R, Gibbs IC, Chang S, Harsh G, Li G, Adler J, Hancook SL, Soltys SG: Repeat Stereotactic Radiosurgery (SRS) for Brain Metastases Locally Recurrent Following Initial SRS. Int J Radiat Oncol‚ Biol‚ Phys 90, S320 (2014)

  • [60]Huang AJ, Huang KE, Page BR, Ayala-Peacock DN, Lucas JT, Jr., Lesser GJ, Laxton AW, Tatter SB, Chan MD: Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery. J Neurooncol 120, 163-9 (2014)

  • [61]Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49, 759-72 (1982)

  • [62]Hermann B, Hultenschmidt B, Sautter-Bihl ML: Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis. Strahlenther Onkol 177, 195-9 (2001)

  • [63]Vincent A, Lesser G, Brown D, Vern-Gross T, Metheny-Barlow L, Lawrence J, Chan MD: Prolonged regression of metastatic leptomeningeal breast cancer that has failed conventional therapy: a case report and review of the literature. J Breast Cancer 16, 122-6 (2013)

  • [64]Brown PD, Asher AL, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Barker FG, Deming RL, Burri S, Menard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Jaeckle KA: NCCTG N0574 (Alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 go 3 brain metastases. J Clin Oncol 33, abstr LBA4 (2015)

  • [65]Dequesada IM, Quisling RG, Yachnis A, Friedman WA: Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 63, 898-903 (2008)

  • [66]Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD: T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 66, 486-91 (2010)

  • [67]Chao ST, Suh JH, Raja S, Lee SY, Barnett G: The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 96, 191-7 (2001)

  • [68]Kimura T, Sako K, Tanaka K, Gotoh T, Yoshida H, Aburano T, Tanaka T, Arai H, Nakada T: Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging. J Neurosurg 100, 835-41. (2004)

  • [69]Matsunaga S, Shuto T, Takase H, Ohtake M, Tomura N, Tanaka T, Sonoda M: Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors. Int J Radiat Oncol Biol Phys 85, 47-52. (2013)

  • [70]Mitsuya K, Nakasu Y, Horiguchi S, Harada H, Nishimura T, Bando E, Okawa H, Furukawa Y, Hiral T, Endo M: Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol 99, 81-8 (2010)

Article Metrics

  • Information

  • Download

  • Contents

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

1 Jan 2016Review

Recent advances in radiosurgical management of brain metastases

Hannah-Marie Devoid 1, Emory R. McTyre 1, Brandi R. Page 1, Linda Metheny-Barlow 1, Jimmy Ruiz 2, Michael D. Chan 1,*
Affiliations
Article Info

1 Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC 27157

2 Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27157

*Author to whom correspondence should be addressed.

 

Abstract

Stereotactic radiosurgery (SRS) has become a widely available treatment option for patients with brain metastases. Recent clinical trials suggest that SRS can be used without upfront whole brain radiotherapy (WBRT), resulting in several clinical dilemmas in the current daily practice of SRS. The proper patient selection for SRS or WBRT continues to evolve. Statistical models to predict when new brain metastases will occur as well as who will experience neurologic death have been developed. The optimization of imaging continues for both detection of brain metastases and response assessment. Larger brain metastases continue to pose a challenge to practitioners to find options to optimize the therapeutic ratio. The current review addresses the current state of the scientific literature for these clinical dilemmas.

Keywords

  • Brain Metastasis
  • Stereotactic Radiosurgery
  • Review

References